Learn more about our work and how we help accelerate the global health response.
Explore how our investments are shaping disease responses.
Learn more
Financial grants to accelerate innovation in global health.
Learn more about the difference our work makes in the lives of people in low- and middle-income countries.
External evaluations provide independent assessments of our work.
Explore the technologies and interventions we're working on.
See where our work is being mentioned in the media world.
Resources for journalists and media representatives.
Unitaid invests US$22m to accelerate access to lenacapavir, a groundbreaking new HIV prevention drug
Unitaid to double its investment in maternal and newborn health with call for proposals that address preeclampsia and anemia
Republic of Korea strengthens global health efforts with US$22 million in support for Unitaid
The last mile in child medicine: The best HIV medicines for the youngest babies
Kenya pioneers a new tool in the fight against malaria
From principle to practice: Involving communities in research design for effective hepatitis C prevention
From promise to impact: Unlocking lenacapavir’s potential to end HIV
With antimicrobial resistance, women and children face highest risks
How COVID-19 unleashed a wave of medical oxygen innovation
February 2014
January 2014
December 2013
No Publications match to search
